Insider Buying: Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Director Buys 1,500 Shares of Stock

Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Get Free Report) Director Catherine Cusack purchased 1,500 shares of the stock in a transaction on Monday, February 24th. The stock was bought at an average price of $15.92 per share, for a total transaction of $23,880.00. Following the completion of the transaction, the director now directly owns 60,583 shares of the company's stock, valued at approximately $964,481.36. This trade represents a 2.54 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Catherine Cusack also recently made the following trade(s):

• On Friday, February 21st, Catherine Cusack purchased 1,000 shares of Sabra Health Care REIT stock. The stock was bought at an average price of $16.43 per share, for a total transaction of $16,430.00.

Sabra Health Care REIT Price Performance

Shares of NASDAQ:SBRA traded up $0.16 during midday trading on Friday, reaching $16.61. The company's stock had a trading volume of 2,969,923 shares, compared to its average volume of 2,086,993. Sabra Health Care REIT, Inc. has a fifty-two week low of $13.31 and a fifty-two week high of $20.03. The company has a market capitalization of $3.95 billion, a P/E ratio of 31.34, a P/E/G ratio of 1.97 and a beta of 1.25. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.32 and a quick ratio of 4.16. The business's fifty day simple moving average is $16.77 and its 200-day simple moving average is $17.61.

Remove Ads

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last announced its quarterly earnings data on Wednesday, February 19th. The real estate investment trust reported $0.36 EPS for the quarter, hitting analysts' consensus estimates of $0.36. The firm had revenue of $182.35 million during the quarter, compared to analyst estimates of $178.01 million. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. As a group, equities research analysts expect that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Health Care REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Friday, February 14th were given a $0.30 dividend. The ex-dividend date was Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a yield of 7.22%. Sabra Health Care REIT's payout ratio is 226.42%.

Institutional Trading of Sabra Health Care REIT

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. VSM Wealth Advisory LLC acquired a new stake in Sabra Health Care REIT in the fourth quarter worth about $26,000. Quarry LP bought a new position in Sabra Health Care REIT during the third quarter worth about $30,000. Assetmark Inc. boosted its holdings in Sabra Health Care REIT by 168.4% during the third quarter. Assetmark Inc. now owns 1,962 shares of the real estate investment trust's stock worth $37,000 after buying an additional 1,231 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new position in Sabra Health Care REIT during the third quarter worth about $59,000. Finally, Harbor Capital Advisors Inc. bought a new position in Sabra Health Care REIT during the third quarter worth about $78,000. 99.40% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. Mizuho reiterated a "neutral" rating and issued a $20.00 price target on shares of Sabra Health Care REIT in a research report on Thursday, December 5th. Truist Financial cut Sabra Health Care REIT from a "buy" rating to a "hold" rating and lowered their price target for the company from $18.00 to $17.00 in a research report on Friday, January 17th. JMP Securities upgraded Sabra Health Care REIT from a "market perform" rating to an "outperform" rating and set a $20.00 target price on the stock in a report on Tuesday, January 7th. Finally, Citizens Jmp upgraded Sabra Health Care REIT from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, January 7th. Three research analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $19.17.

Sabra Health Care REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.